DCB Open Innovation Challenge 2025: Meet our Top 5!

DCB Open Innovation Challenge 2025: Meet our Top 5!

DCB Open Innovation Challenge 2025: Meet our Top 5!

The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 5 who rocked the stage at our Pitch Day and impressed our esteemed jury with their ideas.

Meet our Top 5!

After a thorough review of 54 remarkable submissions for our Open Innovation Challenge, 15 promising teams were invited to present their ideas live at our Pitch Day.

Following an exciting day of pitches and innovation, we are thrilled to announce the 5 finalists who impressed the jury and secured their place in this year’s exclusive bootcamp and a chance to shine at our awards event.

We encourage you to discover the full profiles of our top 5 innovators in the attached PDF or down below!

Join us in celebrating their incredible journey, and secure your ticket for the Day of Innovation to witness the finale in person: https://lnkd.in/dH-8n3v5

Downloads

Alva Innovations Inc. (US) - In-line, just-in-time insulin fibril filtration — NO skin irritation!

Alva Innovations has developed a just-in-time filtration platform that removes insulin fibrils during pump therapy, thereby prolonging the lifespan of pump sets and maintaining healthy skin.

Neuraura (CAN) - LoOoP by Neuraura: proactive management of diabetes risk in PCOS population (polycystic ovary syndrome)

LoOoP by Neuraura is a first in-kind solution for PCOS (polycystic ovary syndrome), combining a biowearable with a digital platform. 70% of individuals with PCOS develop insulin resistance and 50% develop pre-/diabetes before 40.

YW MEMS (CHN) - Insulin patch pump drive

The MEMS MicroPump Module offers a highly integrated, precise, accurate and secure technology for insulin infusion, empowering the miniaturization and intelligent precision control for insulin pump.

SynchNeuro (USA) - Brain signal-based non-invasive glucose monitor

SynchNeuro offers a discreet, brain-signal-based wearable and app for continuous glucose and cardiometabolic monitoring, targeting prediabetic and type 2 diabetes adults for $10/month.

Diawiser (LTU) - Diawiser

Diawiser is a non-invasive software that detects blood glucose abnormalities with voice.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB Open Innovation Challenge 2025: Meet our Top 15!

DCB Open Innovation Challenge 2025: Meet our Top 15!

DCB Open Innovation Challenge 2025: Meet our Top 15!

The DCB Open Innovation Challenge 2025 is proceeding to the next round! We are very happy to announce the Top 15 that have been selected by our evaluation committee.

Meet our Top 15!

After a thorough review of 54 remarkable submissions for our Open Innovation Challenge, our team has identified the 15 most promising ideas to move forward into the next stage.

We are excited to reveal the trailblazing concepts that have earned their place in this year’s cohort. From this talented group, 15 entrants will ultimately be chosen as finalists, securing a spot in our exclusive bootcamp and the chance to shine at our awards event.

We encourage you to discover the full profiles of our top 15 innovators in the attached PDF or down below!

Downloads

Alva Innovations Inc. (US) - In-line, just-in-time insulin fibril filtration — NO skin irritation!

Alva Innovations has developed a just-in-time filtration platform that removes insulin fibrils during pump therapy, thereby prolonging the lifespan of pump sets and maintaining healthy skin.

Diabetes Driving Pal (US) - Diabetes Driving Pal

The Diabetes Driving Pal app makes driving safer for people with diabetes with real-time voice alerts, trend analysis, and community support to prevent low blood sugar–related accidents.

Insuflo (IND) - An affordable insulin pump for people with diabetes

Insuflo is an affordable, discreet, smartphone-controlled insulin pump reducing upfront costs (~$1,200 vs. ~$7,200), combating diabetes stigma, and enabling open-source, community-driven innovation in resource-constrained settings.

Neuraura (CAN) - LoOoP by Neuraura: proactive management of diabetes risk in PCOS population (polycystic ovary syndrome)

LoOoP by Neuraura is a first in-kind solution for PCOS (polycystic ovary syndrome), combining a biowearable with a digital platform. 70% of individuals with PCOS develop insulin resistance and 50% develop pre-/diabetes before 40.

Noxisense (ARG) - Noxisense: Smart Device for Early and Objective Detection of Diabetic Neuropathy

A portable, AI-enhanced device that helps doctors detect diabetic nerve damage early—objectively, non-invasively, and before it leads to pain or amputations.

SynchNeuro (USA) - Brain signal-based non-invasive glucose monitor

SynchNeuro offers a discreet, brain-signal-based wearable and app for continuous glucose and cardiometabolic monitoring, targeting prediabetic and type 2 diabetes adults for $10/month.

U-Pump (USA) - Visage Pioneering the Visual Age

AI-powered wearable insulin patch pump with reusable cartridges, designed for affordability, comfort, and access in underserved diabetes populations.

YW MEMS (CHN) - Insulin patch pump drive

The MEMS MicroPump Module offers a highly integrated, precise, accurate and secure technology for insulin infusion, empowering the miniaturization and intelligent precision control for insulin pump.

Autocast (POL) - System AutoCast - a mission to transform diabetic wound healing

System AutoCast offers advanced wound therapy with smart monitoring at home, empowering patients in their recovery and giving doctors insights that improve care and prevent complications.

Diawiser (LTU) - Diawiser

Diawiser is a non-invasive software that detects blood glucose abnormalities with voice.

Kilele Health (US) - Multiparameter continuous monitoring to improve glucose prediction

Kilele will improve glucose prediction by making real-time hormone levels available to predictive algorithms. This breakthrough uses long-lived aptamer-chemistry biosensors configured similar to CGMs.

Niqs (UK) - QuEST - Quantum Enabled Sensing Technology

NIQS Tech’s GlucoGlass is a reusable, non-invasive glucose sensor offering accurate, eco-friendly diabetes monitoring, with 97% clinical accuracy and no single-use waste.

Preliqx (GER) - Nephronin®

Nephronin® is a highly sensitive and specific test for the early detection of kidney injury. It enables timely intervention and helping prevent kidney failure in patients with diabetes.

Syntactiq (AT) - Syno: Revolutionizing Diabetes Research

Syno revolutionizes diabetes research with a multi-agent AI platform and an unique contextualized dataset (1M+ patient-days), empowering rapid, insightful analysis for clinicians and researchers.

Visage Medical (ISR) - Visage Pioneering the Visual Age

Visage brings life-saving diabetes detection to millions without access to care, using AI and a simple selfie. It’s fast, non-invasive, and built to reach anyone, anywhere.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Diabetes Center Berne @ BEA

Diabetes Center Berne @ BEA

Diabetes Center Berne @ BEA

DCB joined the Focus Day at BEA in Bern, an event highlighting the latest in healthcare innovation. It was a great opportunity to showcase how Diabetes Center Berne is advancing projects that turn research into practical solutions for improving diabetes care.

DC Berne BEA

Speakers and participants had a great time at the Focus Day at BEA in Bern last Saturday! The event at the new Festhalle brought together innovators from across healthcare, with a spotlight on how we can improve patient care and drive digital medicine forward.

A highlight for DCB was the presentation of CEO Derek Brandt, who shared the vision of Diabetes Center Berne. He emphasized how we are committed to improving the lives of people with diabetes through our cutting-edge translational projects.

It was inspiring to be part of such a forward-thinking event, where healthcare leaders like Christoph Ammann, Simon Rothen, and others shared their insights on the future of medicine in Bern. A big thank you to everyone who contributed to making this event a success!

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

Revolutionizing Diabetes Care: How Your Idea Can Make a Global Impact

For the fifth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the five best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB.

Transform Diabetes Care: Your Innovation Could Change Lives

More than 537 million people worldwide live with diabetes, facing daily challenges in managing their condition. Technological innovations have played a crucial role in simplifying diabetes management.

The DCB Open Innovation Challenge, launched in 2021, aims to bridge these gaps by fostering translational research in diabetes technology. Our goal is to identify groundbreaking solutions that enhance the quality of life for those affected by diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable. We’re seeking diverse perspectives and innovative solutions to push diabetes technology forward.

Join and benefit

Following the initial selection phase, the Top 15 teams will enter a mentoring program with expert guidance. From there, the Top 5 teams will be chosen to participate in an exclusive Bootcamp in Switzerland (September 8–11, 2025), where they will receive tailored coaching, mentoring, and media training.

Additionally, finalists will have the opportunity to present their ideas at the DTM Meeting in the USA from October 27-30, 2025. This event offers a fantastic chance to gain exposure in the USA, thanks to our ongoing collaboration with the Diabetes Technology Society.

Finally, the competition will culminate at the Day of Innovation & Award Ceremony in Bern, Switzerland (November 5, 2025), where an international expert jury will select the winning project.

The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support – making the DCB Open Innovation Challenge the world’s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field – all while your idea remains entirely yours.

Don’t miss this opportunity to turn your innovation into reality.

Submit your idea by April 30, 2025, on our innovation platform: innovation.dcberne.com

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ Launches AI-Powered Glucose Prediction feature

SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing diabetes care.

The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.

SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the company’s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.

For more details, read the full press release or visit SNAQ’s website to learn more about their innovations in diabetes care.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025

Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused research, as featured in the special issue of Finanz und Wirtschaft.

DCB in Finanz und Wirtschaft special

A unique aspect of DCB is its close collaboration with the diabetes community, integrating their needs and experiences into research and development processes. DCB also partners with international research and industry organizations to enhance healthcare efficiency and improve the quality of life for people with diabetes.

On the right, you can download the entire article in German.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland